While not easy, should the political will be mustered, the process of breaking the stranglehold Big Pharma has on us would be surprisingly simple. Six changes in Federal law — four repeals of existing law, and two new pieces of legislation — would go a long way toward reining in and even reforming Big Pharma.

From the 1970s onward, U.S. federal policy consistently trended toward the empowerment and enrichment of the pharmaceutical industry.

Since 1980, a series of federal laws were enacted that created perverse incentives and promoted the rapacious behavior that has characterized Big Pharma over the past several decades, climaxing with the pandemic totalitarianism of the COVID-19 era.